Document Type : Original Research
Authors
1 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
2 Interventional Radiology Department, Faculty of Medicine, Ain Shams University
3 Pediatric Surgery Department, Faculty of Medicine, Ain Shams University, Egypt
4 Pathology Department, Faculty of Medicine, Ain Shams University, Egypt
5 Pathology Department, Faculty of Medicine, Cairo University, Egypt
6 Pediatric Surgery Department, Faculty of Medicine, Cairo University, Egypt
Abstract
Keywords
Introduction
Chronic venous ischemia in a closed compartment results in congestion, arterial blood supply impediment and consequent cellular death (2, 3). Ulcer formation and cellular debris removal via immune system is a consequence (4). Hepatic venous outflow obstruction is a surgical complication of liver transplantation, that is known to present as an acute obstructive venous outflow with development of congestive hepatopathy, and graft loss unless timely managed (5). Chronic hepatic venous outflow insufficiency (CHVOI) following liver transplantation was never reported in children recipients of liver transplant grafts. CHVOI has been reported in children with veno-occlusive disease, those with Budd Chiari syndrome and restrictive cardiomyopathy and right sided heart failure (6). Ductopenia, chronic hepatocyte loss and progressive fibrosis over time are the whole-mark of chronic venous outflow insufficiency, irrespective of etiology and are also the same features of chronic liver transplant rejection (7, 8).
Operative hepatic venous reconstruction during liver transplant, done in children who are recipients of liver grafts, is expected to meet current flow, and to meet future remodeling. Future remodeling is a need to accommodate flow required by the growth in size of the children as they attain their adult height, weight and size (9, 10). We made the diagnosis of CHVOI in 7 children recipients of living related liver transplant, based upon the findings on magnetic resonance venography (MRV) and interventional radiogram of hepatic vessels. All underwent graft biopsy that showed features of chronic liver transplant rejection as interpreted by highly experienced pathologists. They improved timely upon interventional dilation, but the improvement was not sustained as the tightness recurred. Despite the lack of complete obstruction of venous outflow, we propose that the CHVOI causes slow steady engorgement of liver graft that initiates a sequence of chain reactions involving immune system ending in subclinical venous ischemia chronic, obliterative arteriopathy and bile duct loss. We aim to describe our experience with CHVOI among children recipients of living related liver transplant.
Participants
In this retrospective observational cohort study we analyzed data of 7 children recipients of living related liver transplant who suffered from CHVOI. The study was approved by Higher Studies Research Committee of Faculty of Medicine, Cairo University.
Methods
Analysis was performed of all data of studied cohort, including indication for transplantation, procedures, diagnostic criteria for diagnosis of CHVOI and outcome.
Statistical Analysis
Results were tabulated and analyzed statistically using SPSS software program (SPSS Statistics for Windows, Version 17.0. Chicago: SPSS Inc).
Results
Our study included 7 children (3 girls and 4 boys) who received liver transplantation for familial hypercholesterolemia, primary familial intrahepatic cholestasis type 3, Crigler Najjar syndrome and end stage liver disease following biliary atresia. The mean age at transplantation was 6 years and 8 months. They all underwent same technique of hepatic vein anastomosis.
After the native liver was removed, a vascular clamp was applied over the three hepatic veins of the recipient, making sure as possible not to completely occlude the lumen of the inferior vena cava (IVC). The 3 hepatic veins were opened into a single orifice by dividing the septa between them, and a triangulated end-to-end continuous anastomosis between the left hepatic vein of the graft and the confluence of the three hepatic veins of the recipient was done using three separate ampoules of 5/0 polydioxanone (PDS) sutures taking care to fix the anastomosis at three points to avoid rotation of the graft over the axis of the IVC and venous occlusion.
Within 8.5± 1.7 months from transplantation, they all presented with jaundice then developed ascites and hepatosplenomegaly. Imaging revealed insufficiency of hepatic venous outflow. Percutaneous liver biopsy consistently revealed a picture of chronic rejection (Figures 1,2 and 3). One child had stent placement in surgically fashioned hepatic venous outflow. All others underwent initial improvement after interventional dilation, but it was not sustained. Six had irreversible progressive course and developed end stage liver disease. All 6 were indicated for re-transplant. Of them 5 died awaiting liver transplant. Tables 1, 2 describe the clinical presentation and outcomes of the studied cohort.
Table 1: Presentation and outcome of children recipients of liver transplant with chronic hepatic venous outflow insufficiency (CHVOI).
|
Child 1 |
Child 2 |
Child 3 |
Child 4 |
Child 5 |
Child 6 |
Child 7 |
Gender |
Boy |
Boy |
Girl |
Girl |
Boy |
Boy |
Girl |
Age at transplantation |
18 months |
9 years, 9 months |
3years, 9months |
5 years, 6 months |
8 years, 2months |
8 years, 3 months |
13 months |
Indication for transplantation |
Biliary Atresia |
PFIC3 |
Biliary Atresia |
FH |
PFIC3 |
Crigler Najjar |
Biliary atresia |
Age at chronic rejection |
26 months |
10 years 4 months |
4years 7 months |
6years 3months |
8 years 9 months |
8years 9 months |
2 years 2 months |
Early post-operative events |
- acute rejection, - Ascites that resolved within 2 month, - Followed by chronic rejection within 8 months |
- acute rejection, - Massive ascites and cholestasis responding to pigtail placement |
- Ascites (resolved in 2 months)
|
- Ascites (resolved in 2 months) - Acute rejection (after 4 month) - Poor response to immunosuppressive medications |
-Acute rejection, massive ascites and graft function loss -responded to surgical graft repositioning
|
-Acute rejection, massive ascites (responded to surgical graft repositioning)- Chronic rejection (8 months later)
|
- acute rejection (6months later) |
Presentation of chronic hepatic venous outflow insufficiency and venous ischemia |
Cholestasis and chronic rejection not responsive to immune suppression |
Ascites that resolved after placement of stent placement 8 months post-operative and HSM |
Cholestasis, chronic rejection that is not responsive to immune suppression, short stature, ascites, liver cell failure |
Cholestasis, chronic rejection not responsive to immune suppression, hyperchol- esterolemia, ascites and liver cell failure |
Cholestasis, chronic rejection not responsive to immune suppression, ascites and liver cell failure |
Cholestasis, chronic rejection not responsive to immune suppression, ascites, liver cell failure, intestinal obstruction, septicemia and death |
Cholestasis, chronic rejection not responsive to immune suppression, ascites and liver cell failure
|
Biopsy Chronic Rejection Banff score (11) |
3/9 |
4/9 |
3/9 |
4/9 |
4/9 |
3/9 |
4/9 |
Pathology Findings |
Non had dilated sinusoids, congestion of central veins or hemorrhages. All had ductopenia, degenerative changes in remaining bile ducts, cholestasis, moderate to severe fibrosis, zone 3 hepatocyte variable inflammation, inflammatory cells in portal tract and hepatic parenchyma, and endothelitis or perivenular fibrosis. Stigmata of venous outflow insufficiency was also noted: dilatation and congestion of some sinusoids and collagen fiber deposition in other sinusoids were also encountered. They all progressed to cirrhosis. |
CHVOI: Chronic hepatic venous outflow insufficiency; FH: Familial hypercholesterolemia; HSM: hepatosplenomegaly; PFIC3: Progressive intrahepatic cholestasis type3.
Immediate post-operative findings were consistent. All children had lactic acidosis lasting 36-48 hours post-operatively. During this period, the children struggled with ascites. Abdominal drains collected ascitic volume more than urine output volume for same duration. All had difficulty to raise and maintain central venous pressure to around 5mm Hg despite a positive balance of fluid intake. Intraoperative Doppler did not show complete obstruction. They all had chest symptoms ranging from wheezes, effusions to frank adult respiratory distress syndrome during the immediate post-operative 12 hour duration. The chest symptoms improved and waned by surgical interventions and diuretics. After a honeymoon period of less than a year they all presented with symptoms of CHVOI. They all had biliary ischemic strictures as well. A girl and a boy had intestinal obstruction heralding the development of CHVOI. One was operated upon where adhesions were found around area of venous outflow reconstruction beside other areas while and the other died during preparation for surgical exploration for cause of intestinal obstruction.
Figure 1: Liver allograft biopsy revealed evidence of chronic rejection of case 3. Stigmata of chronic venous outflow insufficiency are also present: dilatation and congestion of some sinusoids (arrow) and collagen fiber deposition in other sinusoids (arrow head) (Mallory trichrome, original magnification X400).
Table 2: Outcome of children recipients of liver transplant with chronic hepatic venous outflow insufficiency (CHVOI).
|
Child 1 |
Child 2 |
Child 3 |
Child 4 |
Child 5 |
Child 6 |
Child 7 |
Gender |
Boy |
Boy |
Girl |
Girl |
Boy |
Boy |
Girl |
Intervention |
|
Stent placement by intervention radiography. Stent was occluded and needed balloon dilatation |
Stent placement by intervention radiography |
|
Anastomotic dilation by intervention radiography |
|
Re-transplant
|
Imaging diagnostic of CHVOI |
MRV |
Spiral CT, MRV. Venous outflow dilation twice by intervention-al radiograph, followed by failure of dilation |
MRV |
MRV |
Spiral CT, MRV. Venous outflow dilation twice by intervention-al radiograph, followed by failure of dilation |
MRV |
- Imaging studies were negative for CHVOI -Operative finding of incomplete axial torsion of constructed HV of first transplant |
Outcome |
Died within 9months of diagnosis |
Portal hypertension-HSM & mild ascites |
Poorly controlled cholestasis, liver cell failure awaiting re-transplant |
Died within 9months of diagnosis |
Poorly controlled cholestasis, liver cell failure awaiting re-transplant |
Died within 12months of diagnosis |
Died 3 days following re-transplant |
CHVOI: Chronic hepatic venous outflow insufficiency; HV: hepatic veins; HSM: hepatosplenomegaly; MRV: magnetic resonance venography.
Figure 2: Post liver transplant one year earlier with cholestasis, hepatomegaly, biopsy suggests chronic rejection and clinical suspicion of chronic venous outflow insufficiency. (A) Transhepatic venography showed tight stenosis between left hepatic vein and IVC, (B) After passing a guidewire and dilatation using a 6 mm x 4 cm balloon with loss of balloon waist, (C) Final venography, (D) Loss of stricture with drop of pressure gradient less than 3 mm Hg, finally coil embolization.
Discussion
Not all Chronic Rejection is a Primary Immune Response Due to Innate Developmental factors. Recipient histocompatibility genes and resultant antigens are incriminated as potential causes of chronic rejection that has poor prognosis and is not amenable to therapy. The major histocompatibility complex is a human leukocyte antigen system is being currently considered the most aggressive contributor to allograft rejection (12). While primary immune response dictated by human leukocyte antigen is undeniably a crucial factor in development of allograft rejection, yet secondary immune response due to venous congestion is a factor that has to be always in the back of the mind of the transplantation team as it is a preventable cause of rejection.
CHVOI is Incomplete Insidious Venous outflow Obstruction. The liver capsule comprises an invagination of the peritoneum and the Glisson capsule. Once chronic insufficiency of hepatic venous outflow commences the graft will undergo 3 phases: 1- the liver graft gets congested, enlarges and initially the graft oozes fluid through the stretched capsule, resulting in transudate within the peritoneal cavity. 2- As the transudate organizes on surface of capsule, fibrosis and thickening of the capsule does not allow further enlargement of the graft, or transudate. Honeymoon period sets in and the graft is slowly decompensated with gradual rise of pressure within the graft rises leading to hepatocyte necrosis and fibrosis. 3- Stage of decompensation sets in with development of cirrhosis, portal hypertension and ascites. (Figure 4).
Figure 3: Case 2: 10 year old male with history of liver transplant 2 years earlier, and left hepatic vein stent placement with symptoms of hepatic outflow insufficiency. (A) Venography with occluded stent and faint filling of the IVC. Note the presence of collaterals (arrows). (B) Balloon dilatation of the stent with 8 mm balloon. (C & D) Final venography with filling of the IVC and disappearance of collaterals.
Post-operative accumulation of ascites volume more than amount of urine output, central venous pressure dropping despite maintained positive fluid balance, and development of chest symptoms (range from wheezes to full blown adult respiratory distress syndrome) is a triad that diagnoses CHVOI. The respiratory component is accentuated among those with more inadequacy of hepatic venous outflow anastomosis. The respiratory component results from decrement of venous return. The right side of heart pushes less blood to lungs, with drop of pressure in pulmonary vessels and rise of fluid in interstitium. Pulmonary complications range from mild pulmonary edema, adult respiratory distress syndrome till a full blown pulmonary hemorrhage. The magnitude of the respiratory component is reflected as low cardiac output symptoms, where kidneys struggle with hypo perfusion and ischemia. Absent respiratory component occurs in the subtle inadequacy of hepatic venous outflow.
Figure 4: Pathogenesis of chronic hepatic venous outflow insufficiency (CHVOI) post-liver transplantation.
HA: hepatic artery, HV: hepatic veins, IVC: inferior vena cava, PV: portal vein, RHV: reconstructed hepatic vein surgically. a. Recipient hepatectomy. The native liver was removed a vascular clamp was applied over the three hepatic veins of the recipient, making sure as possible not to completely occlude the lumen of the IVC. b. Anhepatic phase almost 20-30 minutes. Hepatic vein anastomosis: The 3 hepatic veins are opened into a single orifice by dividing the septa between them, and a triangulated end-to-end continuous anastomosis between the left hepatic vein of the graft and the confluence of the three hepatic veins of the recipient is done using three separate ampoules of 5/0 PDS sutures taking care to fix the anastomosis at three points to avoid rotation of the graft over the axis of the IVC and venous occlusion. Anhepatic phase is associated with lactic acidosis, and peripheral pre-capillary sphincter release, and reduced venous return. c. The implantation of the graft and vascular anastomoses. Intraoperative doppler assesses the venous return in the reconstructed hepatic venous outflow. The volume flowing across the RHV is less than normal of child, as the venues return is reduced as outlined in (b). d. Graft gets engorged post-operatively as venous return volume increases after clearance of lactic acidosis. The increased pressure within the graft causes oozing of ascites of high protein content. d. The ascitic fluid protein content organizes on the surface of the capsule of the liver graft. Capsule becomes tough and pressure within graft increases, causing subtle venous ischemia, obliterative arteriopathy, bile duct loss, cholestasis pericentral, pericentral hepatocyte ballooning and dropout, progressive fibrosis, portal hypertension, splenomegaly and ascites.
CHVOI Leads to Insidious Venous Ischemia in the Compartmentalized transplanted Liver. The restricted outflow results in low-flow and hepatic congestion, with subsequent hepatocyte necrosis and ischemic ductopenia.
Misleading Factors that Mask the Prompt Diagnosis of CHVOI:
Generous venous outflow reconstruction prevents CHVOI, venous ischemia and chronic rejection. It is regrettable that outcome of CHVOI is related to its early prompt recognition and stent placement, and not mere venous outflow dilation. The biopsy findings are confounding and delay the diagnosis, where treating physicians spend a lot of time attempting to provide suitable medical treatment, while it is surgical condition. The intra-operative Doppler imaging is not a suitable guide for adequacy of the reconstructed hepatic venous outflow.
Pre-operative planning of generous hepatic venous outflow is a must. It is not clear how much of the cases that are diagnosed as chronic rejection have a degree of CHVOI and venous ischemia. It is important to notice that terminal hepatic venules involvement is a feature of chronic rejection.(24) The reconstruction of hepatic venous outflow is a single most important factor to prevent CHVOI.
Conclusion
CHVOI in children leads to graft loss and presents as chronic rejection. CHVOI should be ruled out in any child presenting with chronic rejection. Stent placement is life-saving. Pre-emptive very generous hepatic venous outflow surgical reconstruction technique should be planned, individualized and secured during liver transplant. Not all rejection is a primary immune response. CHVOI is a preventable cause of graft loss.
Acknowledgment
The authors would like to acknowledge the efforts of late Professor Alaa F. Hamza, Late Professor of Pediatric Surgery and Former President of Ain Shams University, Egypt and Professor Ahmed Kotb, Late Professor of Pediatrics, Faculty of Medicine, Cairo University, Egypt.
Author Contributions:
All authors shared in conceptualization, supervising, data curation, data analysis, writing original draft, data interpretation, writing original draft, supervising and revising. All authors reviewed the final manuscript. All authors have read and agreed to the published version of the manuscript.
FUNDING
Authors declare there was no extramural funding provided for this study.
CONFLICT OF INTEREST
The authors declare no conflict of interest in connection with the study.